82.79
0.00 (0.00%)
| Previous Close | 82.79 |
| Open | 83.23 |
| Volume | 559,608 |
| Avg. Volume (3M) | 723,746 |
| Market Cap | 6,386,946,048 |
| Price / Sales | 3.21 |
| Price / Book | 6.03 |
| 52 Weeks Range | |
| Earnings Date | 10 Nov 2025 |
| Profit Margin | -1.73% |
| Operating Margin (TTM) | -3.73% |
| Diluted EPS (TTM) | -0.430 |
| Quarterly Revenue Growth (YOY) | 9.20% |
| Quarterly Earnings Growth (YOY) | -81.70% |
| Total Debt/Equity (MRQ) | 153.63% |
| Current Ratio (MRQ) | 2.01 |
| Operating Cash Flow (TTM) | 257.42 M |
| Levered Free Cash Flow (TTM) | 109.53 M |
| Return on Assets (TTM) | 1.65% |
| Return on Equity (TTM) | 0.33% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Bullish | Mixed |
| Diagnostics & Research (Global) | Bullish | Mixed | |
| Stock | RadNet, Inc. | Bullish | Bearish |
AIStockmoo Score
| Analyst Consensus | 3.0 |
| Insider Activity | -5.0 |
| Price Volatility | -0.5 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 2.0 |
| Average | -0.30 |
|
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Small Growth |
| % Held by Insiders | 12.75% |
| % Held by Institutions | 91.67% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 90.00 (Truist Securities, 8.71%) | Buy |
| Median | 87.00 (5.09%) | |
| Low | 86.00 (Barclays, 3.88%) | Buy |
| Average | 87.67 (5.89%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 76.90 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| B. Riley Securities | 01 Dec 2025 | 87.00 (5.09%) | Buy | 82.79 |
| Barclays | 13 Nov 2025 | 86.00 (3.88%) | Buy | 73.46 |
| 03 Sep 2025 | 79.00 (-4.58%) | Buy | 70.95 | |
| Truist Securities | 12 Nov 2025 | 90.00 (8.71%) | Buy | 74.45 |
| 03 Sep 2025 | 81.00 (-2.16%) | Buy | 70.95 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BERGER HOWARD G | - | - | 0 | 0 |
| PATEL MITAL | - | 79.73 | -25,000 | -1,996,040 |
| Aggregate Net Quantity | -25,000 | |||
| Aggregate Net Value ($) | -1,996,040 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 79.73 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| PATEL MITAL | Officer | 19 Nov 2025 | Sell (-) | 15,080 | 80.29 | 1,210,773 |
| BERGER HOWARD G | Officer | 19 Nov 2025 | Option execute | 129,961 | - | - |
| PATEL MITAL | Officer | 18 Nov 2025 | Sell (-) | 9,920 | 79.16 | 785,267 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |